Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""lamivudine"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 9575
Tytuł:
Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in Zimbabwe.
Autorzy:
Kouamou V; Unit of Internal Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare P.O. Box A178, Zimbabwe.; Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.
Washaya T; Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.
Ndhlovu CE; Unit of Internal Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare P.O. Box A178, Zimbabwe.
Manasa J; Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Sep 05; Vol. 15 (9). Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lamivudine*/pharmacology
Lamivudine*/therapeutic use
Adult ; Humans ; Tenofovir/therapeutic use ; Zimbabwe/epidemiology ; Prevalence ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV.
Autorzy:
Mazzitelli M; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.
Sasset L; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.
Gardin S; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.
Leoni D; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.
Trunfio M; Infectious Diseases Unit, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, 10149 Turin, Italy.; HIV Neurobehavioral Research Program, Departments of Neurosciences and Psychiatry, School of Medicine, University of California, San Diego, CA 92093, USA.
Scaglione V; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.
Mengato D; Hospital Pharmacy Unit, Padua University Hospital, 35128 Padua, Italy.
Agostini E; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.
Vania E; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.; Infectious Disease Unit, Department of Medicine, University of Udine, 33100 Udine, Italy.
Putaggio C; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.
Cattelan A; Infectious and Tropical Diseases Unit, Padua University Hospital, 35128 Padua, Italy.; Department of Molecular Medicine, University of Padua, 35131 Padua, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 15; Vol. 15 (8). Date of Electronic Publication: 2023 Aug 15.
Typ publikacji:
Journal Article
MeSH Terms:
Lamivudine*/therapeutic use
HIV Infections*/drug therapy
Aged ; Male ; Humans ; Female ; Silver ; Heterocyclic Compounds, 3-Ring/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Harmonic Vibrational Frequency Simulation of Pharmaceutical Molecules via a Novel Multi-Molecular Fragment Interception Method.
Autorzy:
Wang L; School of Chemical Engineering, Shandong Institute of Petroleum and Chemical Technology, Dongying 257061, China.
Zhang P; School of Chemical Engineering, Shandong Institute of Petroleum and Chemical Technology, Dongying 257061, China.
Geng Y; School of Chemical Engineering, Shandong Institute of Petroleum and Chemical Technology, Dongying 257061, China.
Zhu Z; School of Chemical Engineering, Shandong Institute of Petroleum and Chemical Technology, Dongying 257061, China.
Yuan S; School of Chemical Engineering, Shandong Institute of Petroleum and Chemical Technology, Dongying 257061, China.; School of Chemistry and Chemical Engineering, Shandong University, Jinan 250199, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jun 08; Vol. 28 (12). Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Lamivudine*
Finasteride*
Molecular Conformation ; Spectroscopy, Fourier Transform Infrared ; Spectrum Analysis, Raman ; Pharmaceutical Preparations ; Quantum Theory ; Vibration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain.
Autorzy:
Sequera-Arquelladas S; Unit of Infectious Diseases, Instituto de Investigación Biosanitario de Granada (IBS-Granada), Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Hidalgo-Tenorio C; Unit of Infectious Diseases, Instituto de Investigación Biosanitario de Granada (IBS-Granada), Virgen de las Nieves University Hospital, 18014 Granada, Spain.
López-Cortés L; Department of Infectious Diseases, Virgen del Rocio University Hospitals, 41013 Seville, Spain.
Gutiérrez A; Department of Infectious Diseases, Virgen del Rocio University Hospitals, 41013 Seville, Spain.
Santos J; IBIMA Plataforma BIONAND, Unit of Infectious Diseases, Virgen de la Victoria University Hospital, 29010 Málaga, Spain.
Téllez F; Unit of Infectious Diseases, Puerto Real Universitary Hospital, 11510 Cádiz, Spain.
Omar M; Unit of Infectious Diseases, Hospital Complex of Jaen, 23007 Jaén, Spain.
Ferra-Murcia S; Unit of Infectious Diseases, Hospital Torrecárdenas Hospital, 04009 Almería, Spain.
Fernández E; Internal medicine Service, Hospital Poniente, 04700 Almería, Spain.
Javier R; Unit of Infectious Diseases, Instituto de Investigación Biosanitario de Granada (IBS-Granada), Virgen de las Nieves University Hospital, 18014 Granada, Spain.
García-Vallecillos C; Unit of Infectious Diseases, Instituto de Investigación Biosanitario de Granada (IBS-Granada), Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Pasquau J; Unit of Infectious Diseases, Instituto de Investigación Biosanitario de Granada (IBS-Granada), Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 06; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV-1*
Anti-HIV Agents*/adverse effects
HIV Seropositivity*
Oxazines*
Piperazines*
Pyridones*
Humans ; Middle Aged ; Lamivudine/adverse effects ; Spain ; Heterocyclic Compounds, 3-Ring/adverse effects ; Anti-Retroviral Agents/therapeutic use ; Lipids
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.
Autorzy:
Walmsley, Sharon (AUTHOR)
Smith, Don E. (AUTHOR)
Górgolas, Miguel (AUTHOR)
Cahn, Pedro E. (AUTHOR)
Lutz, Thomas (AUTHOR)
Lacombe, Karine (AUTHOR)
Kumar, Princy N. (AUTHOR)
Wynne, Brian (AUTHOR)
Grove, Richard (AUTHOR)
Bontempo, Gilda (AUTHOR)
Moodley, Riya (AUTHOR)
Okoli, Chinyere (AUTHOR)
Kisare, Michelle (AUTHOR)
Jones, Bryn (AUTHOR)
Clark, Andrew (AUTHOR)
Ait-Khaled, Mounir (AUTHOR)
Pokaż więcej
Źródło:
AIDS Research & Therapy. 3/21/2024, Vol. 21 Issue 1, p1-9. 9p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies.
Autorzy:
Underwood, Mark (AUTHOR)
Urbaityte, Rimgaile (AUTHOR)
Wang, Ruolan (AUTHOR)
Horton, Joe (AUTHOR)
Oyee, James (AUTHOR)
Wynne, Brian (AUTHOR)
Fox, Dainielle (AUTHOR)
Jones, Bryn (AUTHOR)
Man, Choy (AUTHOR)
Sievers, Jörg (AUTHOR)
Pokaż więcej
Źródło:
Viruses (1999-4915). Mar024, Vol. 16 Issue 3, p405. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
Autorzy:
Nasreddine R; Saint-Pierre University Hospital, Brussels, Belgium.
Yombi JC; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Darcis G; Liège University Hospital, Liège, Belgium.
Florence E; Institute of Tropical Medicine, Antwerp, Belgium.
Allard SD; Universitair Ziekenhuis Brussel, Brussels, Belgium.
De Scheerder MA; Ghent University Hospital, Ghent, Belgium.
Henrard S; University Clinics of Brussels - Erasme Hospital, Brussels, Belgium.
Demeester R; University Hospital of Charleroi, Lodelinsart, Belgium.
Messiaen P; Jessa Hospital, Hasselt, Belgium.
Ausselet N; UCL University Hospital Namur-Godinne, Yvoir, Belgium.
Loeckx M; ViiV Healthcare, Belgium.
Delforge M; Saint-Pierre University Hospital, Brussels, Belgium.
De Wit S; Saint-Pierre University Hospital, Brussels, Belgium.
Pokaż więcej
Corporate Authors:
Belgian Research on AIDS and HIV Consortium (BREACH)
Źródło:
HIV medicine [HIV Med] 2023 Mar; Vol. 24 (3), pp. 267-278. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Lamivudine*/therapeutic use
Rilpivirine*/therapeutic use
Female ; Humans ; Male ; Middle Aged ; Belgium ; Drug Combinations ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review.
Autorzy:
Chu C; Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA 94110, USA.
Tao K; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Kouamou V; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare 00263, Zimbabwe.
Avalos A; Careena Center for Health, Gaborone, Botswana.
Scott J; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Grant PM; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Rhee SY; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
McCluskey SM; Division of Infectious Diseases, Harvard Medical School, Boston, MA 02115, USA.
Jordan MR; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA 02111, USA.; Collaboratory for Emerging Infectious Diseases and Response (CEIDR), Tufts University, Medford, MA 02155, USA.
Morgan RL; School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Mar 04; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Integrase Inhibitors*/therapeutic use
HIV Integrase Inhibitors*/pharmacology
Anti-HIV Agents*/therapeutic use
Oxazines*
Piperazines*
Pyridones*
Humans ; Cross-Sectional Studies ; Prevalence ; Lamivudine/therapeutic use ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Heterocyclic Compounds, 3-Ring/pharmacology ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bidirectional pharmacokinetics of doravirine, tenofovir, and feminizing hormones in transgender women (IDentify): A randomized crossover trial.
Autorzy:
Lam K; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Kraft WK; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Zhan T; Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Lam E; Clinical Pharmacokinetics Research Lab, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13721.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Transgender Persons*
Anti-HIV Agents*/adverse effects
HIV Infections*/drug therapy
Pyridones*
Triazoles*
Humans ; Female ; Tenofovir/adverse effects ; Cross-Over Studies ; Spironolactone ; Lamivudine ; Estradiol ; Testosterone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.
Autorzy:
Minja M; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, The Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Mbilinyi T; Department of Pharmaceutical Microbiology, School of Pharmacy, The Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Mkinga B; Department of Pharmacognosy, School of Pharmacy, The Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Philipo EG; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, The Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Owenya J; Department of Pharmacy, Temeke Regional Referral Hospital, Dar es Salaam, Tanzania.
Kilonzi M; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, The Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 27; Vol. 19 (2), pp. e0294940. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Meningitis, Cryptococcal*/drug therapy
Meningitis, Cryptococcal*/epidemiology
Meningitis, Cryptococcal*/complications
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Female ; Adult ; Middle Aged ; Integrase Inhibitors/therapeutic use ; Fluconazole/therapeutic use ; Tanzania/epidemiology ; Cross-Sectional Studies ; Prevalence ; Retrospective Studies ; Anti-Retroviral Agents/therapeutic use ; Lamivudine/therapeutic use ; Tenofovir/therapeutic use ; Heterocyclic Compounds, 1-Ring
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch.
Autorzy:
Malagnino V; Infectious Disease Unit, Policlinico Tor Vergata of Rome, 00133 Rome, Italy.; Department of System Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.
Mulas T; Infectious Disease Unit, Policlinico Tor Vergata of Rome, 00133 Rome, Italy.
Teti E; Infectious Disease Unit, Policlinico Tor Vergata of Rome, 00133 Rome, Italy.
Basso M; Department of Molecular Medicine, University of Padova, 35128 Padova, Italy.
Giobbia M; Infectious Disease Unit, Ospedale di Treviso, 31100 Treviso, Italy.
Geremia N; Infectious Disease Unit, Ospedale di Venezia, 30122 Venezia, Italy.
Battagin G; Infectious Disease Unit, Ospedale di Vicenza, 36100 Vicenza, Italy.
Abi Aad Y; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, Cedex 12, 75571 Paris, France.
Vincensini JP; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, Cedex 12, 75571 Paris, France.
Iannetta M; Infectious Disease Unit, Policlinico Tor Vergata of Rome, 00133 Rome, Italy.; Department of System Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.
Parisi SG; Department of Molecular Medicine, University of Padova, 35128 Padova, Italy.
Sarmati L; Infectious Disease Unit, Policlinico Tor Vergata of Rome, 00133 Rome, Italy.; Department of System Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.
Lacombe K; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, Cedex 12, 75571 Paris, France.; INSERM, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), Sorbonne University, 75646 Paris, France.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 23; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Hepatitis B*/drug therapy
Oxazines*
Piperazines*
Pyridones*
Humans ; Lamivudine/therapeutic use ; Retrospective Studies ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Risk Factors ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Spherical PEG/SiO 2 promising agents for Lamivudine antiviral drug delivery, a molecular dynamics simulation study.
Autorzy:
Razzaghi S; Department of Chemistry, Faculty of Science, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran.
Vafaee M; Department of Chemistry, Faculty of Science, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran. .
Kharazian B; Faculty of Pharmacy, Nanotechnology Research Center, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, Iran. .
Nasrollahpour M; Department of Chemistry, Faculty of Science, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 27; Vol. 13 (1), pp. 3323. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents*
Lamivudine*
Humans ; Silicon Dioxide ; Polyethylene Glycols ; Molecular Dynamics Simulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis.
Autorzy:
Henriquez-Camacho C; Faculty of Medicine, Universidad Francisco de Vitoria (UFV), Hospital Universitario de Móstoles, 28935 Madrid, Spain.
Hijas-Gomez AI; Agencia de Evaluación de Tecnologías Sanitarias (AETS), Instituto de Salud Carlos III, 28220 Madrid, Spain.
Risco Risco C; HM Hospitales, Hospital Universitario Sanchinarro, 28050 Madrid, Spain.
Ruiz Lapuente MA; Centro de Vacunación Internacional, Sanidad Exterior Barcelona, 08002 Barcelona, Spain.
Escudero-Sanchez R; Hospital Universitario Ramón y Cajal, CIBERINFEC, ISIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, IRYCIS, Instituto Ramón y Cajal de Investigación Sanitaria, 28034 Madrid, Spain.
Cuerda VM; Faculty of Medicine, Universidad Francisco de Vitoria (UFV), Hospital Universitario de Móstoles, 28935 Madrid, Spain.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Nov 10; Vol. 15 (11). Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Hepatitis B*/complications
Hepatitis B, Chronic*
Adult ; Humans ; Lamivudine/therapeutic use ; Antiviral Agents/pharmacology ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Treatment Outcome ; DNA, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores.
Autorzy:
Okan HD; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Karabay O; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Guclu E; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Inci MB; Department of Public Health, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Ogutlu A; Department of Infectious Diseases and Clinic Microbiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey.
Pokaż więcej
Źródło:
Indian journal of pharmacology [Indian J Pharmacol] 2023 Jan-Feb; Vol. 55 (1), pp. 14-20.
Typ publikacji:
Journal Article
MeSH Terms:
Lamivudine*/therapeutic use
Hepatitis B, Chronic*/drug therapy
Humans ; Tenofovir/therapeutic use ; Antiviral Agents/therapeutic use ; Hepatitis B e Antigens/therapeutic use ; Retrospective Studies ; Liver Cirrhosis/drug therapy ; Fibrosis ; Aspartate Aminotransferases ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study.
Autorzy:
Gan, Lin (AUTHOR)
Xie, Xiaoxin (AUTHOR)
Fu, Yanhua (AUTHOR)
Yang, Xiaoyan (AUTHOR)
Ma, Shujing (AUTHOR)
Kong, Linghong (AUTHOR)
Song, Chunli (AUTHOR)
Song, Yebing (AUTHOR)
Ren, Tingting (AUTHOR)
Long, Hai (AUTHOR)
Pokaż więcej
Źródło:
Infectious Diseases & Therapy. Nov2023, Vol. 12 Issue 11, p2581-2593. 13p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines.
Autorzy:
Zanrè V; Section of Biochemistry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Strada Le Grazie, 8, 37134 Verona, Italy.
Bellinato F; Section of Dermatology and Venereology, Department of Medicine, University of Verona, Piazzale Stefani 1, 37126 Verona, Italy.
Cardile A; Section of Biochemistry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Strada Le Grazie, 8, 37134 Verona, Italy.
Passarini C; Section of Biochemistry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Strada Le Grazie, 8, 37134 Verona, Italy.
Monticelli J; Infectious Diseases Unit, Trieste University Hospital (ASUGI), Piazza dell'Ospitale 1, 34129 Trieste, Italy.
Di Bella S; Clinical Department of Medical, Surgical and Health Sciences, University of Trieste, Piazzale Europa 1, 34127 Trieste, Italy.
Menegazzi M; Section of Biochemistry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Strada Le Grazie, 8, 37134 Verona, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 28; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/genetics
Melanoma*/pathology
Endogenous Retroviruses*
HIV Infections*/drug therapy
Pyridones*
Triazoles*
Diketopiperazines*
Humans ; Lamivudine ; B7-H1 Antigen/genetics ; Cell Line, Tumor ; Anti-Retroviral Agents/therapeutic use ; Interferons/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Learning from cerebrospinal fluid drug-resistant HIV escape-associated encephalitis: a case report.
Autorzy:
Kang J; National Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, China.
Wang Z; Dongguan Institute for Microscale and Precision Medical Measurement, Dongguan, China.
Zhou Y; Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China.
Wang W; Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China.
Wen Y; Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Dec 10; Vol. 20 (1), pp. 292. Date of Electronic Publication: 2023 Dec 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Anti-HIV Agents*/pharmacology
Encephalitis*/complications
Encephalitis*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Adult ; Humans ; Male ; Cerebrospinal Fluid ; Lamivudine/therapeutic use ; Prednisone/therapeutic use ; RNA ; RNA, Viral/genetics ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China.
Autorzy:
Li M; Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Chongchuan District, No.9 Seyuan Road, Nantong, Jiangsu, China.; Zhangjiagang Center for Disease Control and Prevention, Department of Infectious Disease Prevention, No.18 Zhizhong Road, Zhangjiagang, Suzhou, Jiangsu, China.
Cao Y; Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Chongchuan District, No.9 Seyuan Road, Nantong, Jiangsu, China.
Huang H; Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Chongchuan District, No.9 Seyuan Road, Nantong, Jiangsu, China.
Qin G; Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Chongchuan District, No.9 Seyuan Road, Nantong, Jiangsu, China.
Chu M; Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Chongchuan District, No.9 Seyuan Road, Nantong, Jiangsu, China.
Zou M; Nantong No.3 hospital affiliated to Nantong University, No.99 Qingnian Zhong Road, Chongchuan District, Nantong, Jiangsu, China.
Zhuang X; Department of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Chongchuan District, No.9 Seyuan Road, Nantong, Jiangsu, China. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2023 Nov 13; Vol. 23 (1), pp. 2228. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Cost-Effectiveness Analysis ; Dideoxynucleosides/adverse effects ; Lamivudine/adverse effects ; Anti-Retroviral Agents/therapeutic use ; Emtricitabine/therapeutic use ; Benzoxazines/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 9575

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies